Skip to content
Disclosery

EXANE DERIVATIVES: CAT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CAT, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,354 CAT shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,354 shares
    Change vs previous 13F -1,283 shares

    0.24% of the 13F portfolio, value $420,708.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,637 shares
    Change vs previous 13F -86 shares

    0.23% of the 13F portfolio, value $810,335.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,723 shares
    Change vs previous 13F -1,989 shares

    0.19% of the 13F portfolio, value $769,655.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 5,712 shares
    Change vs previous 13F +1 shares

    0.27% of the 13F portfolio, value $1,096,478.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 5,711 shares
    Change vs previous 13F -388 shares

    0.29% of the 13F portfolio, value $1,228,912.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 6,099 shares
    Change vs previous 13F +5,572 shares

    0.43% of the 13F portfolio, value $1,414,089.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 527 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $95,919.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).